The Federal Trade Commission said the deal would enable Amgen to exploit its size to block ... forced merging pharmaceutical companies to sell off drugs that treat the same types of diseases ...
The Federal Trade Commission sued to block drugmaker Amgen’s proposed $27.8 billion deal to acquire a smaller rival, the regulator’s first challenge to a pharmaceutical merger in years ...
The Federal Trade Commission sued Tuesday to block Amgen’s $27.8-billion deal to buy Horizon Therapeutics, arguing the tie-up would stifle competition for the development of treatments for ...
The Federal Trade Commission sued to block Amgen's $27.8 billion acquisition of Horizon Therapeutics. The FTC argued that the proposed deal would stifle drug competition in the pharmaceutical ...
The FTC wants to block Amgen's acquisition of Horizon even though the two companies' products don't overlap. The agency thinks that Amgen could try to bundle Horizon's products in a way that ...
Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics The U.S. is attempting to block the proposed acquisition of Horizon ...
An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/ May 18 (Reuters) - Amgen Inc (AMGN.O) has agreed not to quickly close ...
Amgen Inc. (NASDAQ:AMGN) price on Friday, June 09, fall -0.91% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $218.76. A look at the stock’s price ...
An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo May 23 (Reuters) - Johnson & Johnson (JNJ.N) has settled its ...
Bloomberg Intelligence Senior Litigation Analyst, Jennifer Rie and Bloomberg Antitrust Reporter Leah Nylen discuss the latest with the FTC's suit to block Amgen's deal with Horizon Therapeutics.
Shares of Salesforce and Amgen are trading lower Thursday morning, dragging the Dow Jones Industrial Average into negative territory. Shares of ...
The Federal Trade Commission on Tuesday sued to block drugmaker Amgen’s $27.8 billion acquisition ... merging pharmaceutical companies to sell off drugs that treat the same types of diseases ...
